Stock Events

Livzon Pharmaceutical 

¥36.67
11
+¥0+0% Tuesday 06:45

Statistics

Day High
38.2
Day Low
36.3
52W High
41.47
52W Low
31.72
Volume
8,168,307
Avg. Volume
4,955,318
Mkt Cap
30.26B
P/E Ratio
17.94
Dividend Yield
3.68%
Dividend
1.35

Upcoming

Dividends

3.68%Dividend Yield
10Y Growth
10.44%
5Y Growth
2.38%
3Y Growth
2.6%
1Y Growth
-15.63%

Earnings

21AugConfirmed
Q1 2024
Next
0.55
0.59
0.62
0.65
Expected EPS
0.55307092489121
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 000513.SZ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BeiGene
BGNE
Mkt Cap15B
BeiGene is a biotechnology company that competes in the oncology and immunology sectors, similar to Livzon's focus areas.
Zai Lab Limited
ZLAB
Mkt Cap1.86B
Zai Lab Limited operates in the biopharmaceutical field focusing on developing innovative medicines, directly competing with Livzon's pharmaceutical products.
HUTCHMED (China) Limited
HCM
Mkt Cap3.3B
Hutchison China MediTech Limited is involved in discovering, developing, and commercializing pharmaceuticals in oncology and autoimmune diseases, areas that Livzon also targets.
Sinovac Biotech
SVA
Mkt Cap644.66M
Sinovac Biotech Ltd. competes in the vaccine market, particularly in areas where Livzon is also making significant investments.
FibroGen
FGEN
Mkt Cap104.45M
FibroGen, Inc. focuses on discovering, developing, and commercializing a pipeline of therapeutics, competing with Livzon in the biopharmaceutical sector.
Can-Fite Biopharma
CANF
Mkt Cap6.94M
Can-Fite BioPharma Ltd. is engaged in the development of proprietary drugs in the fields of cancer, autoimmune, and inflammatory diseases, competing with Livzon's product range.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops and markets medicines in areas of unmet medical need, overlapping with Livzon's market.
Merck &
MRK
Mkt Cap318.55B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals across various therapeutic areas, including those Livzon is involved in.
Pfizer
PFE
Mkt Cap169.83B
Pfizer Inc. is one of the world's largest pharmaceutical companies, with a broad range of products that compete across several of Livzon's key therapeutic areas.
Novartis
NVS
Mkt Cap232.42B
Novartis AG is a global healthcare company that operates in the pharmaceuticals sector, offering products that directly compete with Livzon Pharmaceutical's offerings.

About

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.
Show more...
CEO
Mr. Yanggang Tang
Country
CN
ISIN
CNE0000002Y8

Listings